Current magnitude and problems of mycoses: Fungal infections or mycoses cause a wide range of diseases in humans. Mycoses range in extent from superficial infections involving the outer layer of the stratum corneum of the skin to disseminated infection involving the brain, heart, lungs, liver, spleen, and kidneys. The range of patients at risk for invasive fungal infections continues to expand beyond the normal host to encompass patients with the acquired immunodeficiency syndrome; those immunosuppressed due to therapy for cancer and organ transplantation, and those undergoing major surgical procedures. Each of these patient populations has a high risk of developing invasive fungal infections. As the population at risk continues to expand so also does the spectrum of opportunistic fungal pathogens infecting these patients also continue to increase. Many of the deeply invasive mycoses are difficult to diagnose early and often difficult to treat effectively. The development of new approaches to diagnosis and treatment of invasive fungal infections is the subject of intensive research.
Concepts of classification: Fungal infections may be classified according to the site of infection, route of acquisition, and type of virulence. When classified according to the site of infection, fungal infections are designated as superficial, cutaneous, subcutaneous, and deep (Fig. 75-1). Superficial mycoses are limited to the stratum corneum and essentially elicit no inflammation. Cutaneous infections involve the integument and its appendages, including hair and nails. Infection may involve the stratum corneum or deeper layers of the epidermis. Inflammation of the skin is elicited by the organism or its products. Subcutaneous mycoses include a range of different infections characterized by infection of the subcutaneous tissues usually at the point of traumatic inoculation. An inflammatory response develops in the subcutaneous tissue frequently with extension into the epidermis. Deep mycoses involve the lungs, abdominal viscera, bones and or central nervous system. The most common portals of entry are the respiratory tract, gastrointestinal tract, and blood vessels (Fig. 75-2).
When classified according to the route of acquisition, a fungal infection may be designated as exogenous or endogenous in origin. If classified as exogenous, an infecting organism may be transmitted by airborne, cutaneous, or percutaneous routes. An endogenously-acquired fungal infection may be acquired from colonization or reactivation of a fungus from a latent infection. Fungi may be classified also according to virulence, as primary pathogens or as opportunistic pathogens. A primary pathogen may establish infection in an immunologically normal host; whereas, an opportunistic pathogen requires some compromise of host defenses in order for infection to become established.
Copyright © 1996, The University of Texas Medical Branch at Galveston.